SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
Clinical trial NCT07744932 · RECRUITING
Trial details
- NCT number
- NCT07744932
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-15
- Primary completion
- 2027-12-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.